-
Mitigating Therapeutic Inertia of GLP-1 Use in T2D
Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 RAs, have recently garnered significant media attention. Initially developed to improve glycemic control in patients with type 2 diabetes, these medications have also proven to…
-
Is the “Diabetic Diet” a Thing of the Past?
If I had a dollar for every time I received a referral to provide education on the so-called “diabetic diet,” I’d be a very wealthy lady! While I understand the good intentions behind…
-
ADCES24: Let the Good Times Role!
It was another great year at the Association of Diabetes Care and Education Specialists annual conference, this time in vibrant New Orleans. Packed full of engaging educational sessions, networking events, and a lively…
-
Over-the-Counter CGM Coming to a Pharmacy Shelf Near You
This has been the summer of over-the-counter CGM announcements. Continuous glucose monitors (CGMs), once only accessible through prescriptions, are now becoming readily available over the counter. This shift marks a significant step forward…
-
4 Clinical Pearls from the 2024 ATDC Conference
I was very fortunate to attend the 2024 ATDC Conference this year in beautiful Keystone, Colorado. The ATDC Conference has been an integral part of education and case-based studies of pipeline diabetes technology…